226 related articles for article (PubMed ID: 19453987)
1. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
Daniel-Johnson J; Leitman S; Klein H; Alter H; Lee-Stroka A; Scheinberg P; Pantin J; Quillen K
Transfusion; 2009 Sep; 49(9):1845-9. PubMed ID: 19453987
[TBL] [Abstract][Full Text] [Related]
2. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
[TBL] [Abstract][Full Text] [Related]
3. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
5. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.
Quillen K; Sheldon SL; Daniel-Johnson JA; Lee-Stroka AH; Flegel WA
Transfusion; 2011 Jan; 51(1):92-6. PubMed ID: 20576015
[TBL] [Abstract][Full Text] [Related]
6. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
Josephson CD; Mullis NC; Van Demark C; Hillyer CD
Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
[TBL] [Abstract][Full Text] [Related]
7. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
8. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
[TBL] [Abstract][Full Text] [Related]
9. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
Berséus O; Boman K; Nessen SC; Westerberg LA
Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
[TBL] [Abstract][Full Text] [Related]
10. Hemolysis following platelet transfusions from ABO-incompatible donors.
Pierce RN; Reich LM; Mayer K
Transfusion; 1985; 25(1):60-2. PubMed ID: 2578692
[TBL] [Abstract][Full Text] [Related]
11. Acute intravascular hemolysis secondaryto out-of-group platelet transfusion.
Larsson LG; Welsh VJ; Ladd DJ
Transfusion; 2000 Aug; 40(8):902-6. PubMed ID: 10960514
[TBL] [Abstract][Full Text] [Related]
12. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
Pagano MB; Katchatag BL; Khoobyari S; Van Gerwen M; Sen N; Rebecca Haley N; Gernsheimer TB; Hess JR; Metcalf RA
Transfusion; 2019 Apr; 59(4):1246-1251. PubMed ID: 30592057
[TBL] [Abstract][Full Text] [Related]
13. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets.
Cooling LL; Downs TA; Butch SH; Davenport RD
Transfusion; 2008 Oct; 48(10):2106-13. PubMed ID: 18631162
[TBL] [Abstract][Full Text] [Related]
14. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
Harris SB; Josephson CD; Kost CB; Hillyer CD
Transfusion; 2007 Aug; 47(8):1412-7. PubMed ID: 17655585
[TBL] [Abstract][Full Text] [Related]
15. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?
Fontaine MJ; Webster J; Gomez S; Pham TD; Goodnough LT; Galel SA
Transfusion; 2015 Dec; 55(12):2783-9. PubMed ID: 26448376
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
[TBL] [Abstract][Full Text] [Related]
17. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
[TBL] [Abstract][Full Text] [Related]
18. Hemolysis after ABO-incompatible platelet transfusions.
Chow MP; Yung CH; Hu HY; Tzeng CH
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Aug; 48(2):131-4. PubMed ID: 1654184
[TBL] [Abstract][Full Text] [Related]
19. Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.
Harm SK; Yazer MH; Bub CB; Cohn CS; Jacob EK; Kutner JM; Mair DC; Raval JS; Shaz BH; Ziman A; Dunbar NM;
Transfusion; 2019 Feb; 59(2):762-767. PubMed ID: 30548267
[TBL] [Abstract][Full Text] [Related]
20. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.
Fung MK; Downes KA; Shulman IA
Arch Pathol Lab Med; 2007 Jun; 131(6):909-16. PubMed ID: 17550318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
